Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis

被引:62
作者
Katz, P. O.
Ginsberg, G. G.
Hoyle, P. E.
Sostek, M. B.
Monyak, J. T.
Silberg, D. G.
机构
[1] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] AstraZeneca LP, Wilmington, DE USA
关键词
D O I
10.1111/j.1365-2036.2006.03235.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim To assess the relationship between the percentage of time intragastric pH > 4.0 and healing of erosive oesophagitis. Methods In this proof-of-concept study, adults with endoscopically verified Los Angeles grade C or grade D erosive oesophagitis were randomly assigned to oral esomeprazole 10 or 40 mg once daily for 4 weeks. On day 5, patients underwent 24-h pH monitoring. At 4 weeks, erosive oesophagitis healing status was endoscopically assessed. Investigators scored gastro-oesophageal reflux disease symptoms on a 4-point scale [none to severe (0-3)] before and 4 weeks after treatment. The percentage of time intragastric pH was > 4.0 and healing status were correlated and tested for significance using a Spearman rank correlation (r). Results 103 patients had evaluable data (mean age, 48.7 years; 65% men). Mean percentages of time with intragastric pH > 4.0 on day 5 in patients with healed and unhealed erosive oesophagitis were 61% and 42%, respectively (P = 0.0002), indicating that erosive oesophagitis healing rates were positively related to the percentage of time intragastric pH was > 4.0. Greater intragastric acid control correlated with lower final daytime and night-time heartburn and acid regurgitation symptom scores (r = -0.029, -0.029 and -0.021; P = 0.003, 0.003 and 0.032, respectively). Conclusion A positive relationship between intragastric acid control and erosive oesophagitis healing was demonstrated.
引用
收藏
页码:617 / 628
页数:12
相关论文
共 30 条
[1]   Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole [J].
Andersson, T ;
Röhss, K ;
Bredberg, E ;
Hassan-Alin, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (10) :1563-1569
[2]  
[Anonymous], 1996, GASTROENTEROLOGY, V110, P1981
[3]   APPROPRIATE ACID SUPPRESSION FOR THE MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
BELL, NJV ;
BURGET, D ;
HOWDEN, CW ;
WILKINSON, J ;
HUNT, RH .
DIGESTION, 1992, 51 :59-67
[4]   The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion [J].
Blum, RA ;
Shi, H ;
Karol, MD ;
GreskiRose, PA ;
Hunt, RH .
CLINICAL THERAPEUTICS, 1997, 19 (05) :1013-1023
[5]   IS THERE AN OPTIMAL DEGREE OF ACID SUPPRESSION FOR HEALING OF DUODENAL-ULCERS - A MODEL OF THE RELATIONSHIP BETWEEN ULCER HEALING AND ACID SUPPRESSION [J].
BURGET, DW ;
CHIVERTON, SG ;
HUNT, RH .
GASTROENTEROLOGY, 1990, 99 (02) :345-351
[6]  
Castell DO, 2002, AM J GASTROENTEROL, V97, P575
[7]   Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis [J].
Chiba, N ;
DeGara, CJ ;
Wilkinson, JM ;
Hunt, RH .
GASTROENTEROLOGY, 1997, 112 (06) :1798-1810
[8]   ROLES OF GASTRIC-ACID AND PH IN THE PATHOGENESIS OF GASTROESOPHAGEAL REFLUX DISEASE [J].
DENT, J .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 :55-61
[9]   Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease [J].
El-Serag, HB ;
Johanson, JF .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (08) :899-904
[10]   Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis [J].
Fennerty, MB ;
Johanson, JF ;
Hwang, C ;
Sostek, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (04) :455-463